Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 10, 2023
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
[ Tue, Jan 10th 2023
] - WOPRAI
Mon, January 9, 2023
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
Jeff Cantwell Maintained (CDLX) at Sell with Decreased Target to $6 on, Jan 9th, 2023
Jeff Cantwell of Wells Fargo, Maintained "Cardlytics, Inc." (CDLX) at Sell with Decreased Target from $10 to $6 on, Jan 9th, 2023.
Jeff has made no other calls on CDLX in the last 4 months.
There is 1 other peer that has a rating on CDLX. Out of the 1 peers that are also analyzing CDLX, 0 agree with Jeff's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jeff
- Kyle Peterson of "Needham" Maintained at Strong Buy with Decreased Target to $14 on, Wednesday, November 2nd, 2022
